Julius Knowles Ph.D Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 5

  • Med. Deal Size

  • Med. Valuation

Julius Knowles Ph.D General Information

Biography

Dr. Julius Knowles serves as a Partner at Mass General Brigham. He serves as an Investment Committee Member at Myeloma Investment Fund. He was Vice President, Business Development, at Novacea and Structural Genomix, and Research and Development Planning Director at Vertex Pharmaceuticals. He has an MBA in Finance from Wharton Business School, an M.Sc. in Chemistry from UC Berkeley, and a BA with Distinction in Chemistry from Carleton College. He represents Mass General Brigham Ventures on the board of Abcuro, Keros, Paros, Proximity, and SwanBio, and as a board observer at ROME, QurAlis, and Triplet Therapeutics. He also holds a Ph.D degree.

Contact Information

Primary Position
Education
University of Pennsylvania (Wharton), MBA (Master of Business Administration)
University of California, Berkeley, MS (Master of Science)
Carleton College, BA (Bachelor of Arts)
Gender
Male
Email
jj
Phone
+1 (617)
Address
  • 399 Revolution Drive
  • Suite 999
  • Somerville, MA 02145
  • United States
+1 (857)

Julius Knowles Ph.D Positions (3)

Firm name Firm type Title Location Industry Since
Mass General Brigham Company Partner Somerville, MA Hospitals/Inpatient Services
Mass General Brigham Innovation Investor Partner Cambridge, MA Corporate Venture Capital
Mass General Brigham Ventures Investor Partner Somerville, MA Venture Capital

Julius Knowles Ph.D Board Seats (5)

Company Industry Ownership Status Financing Status Location Since
Abcuro Drug Discovery Privately Held (backing) Venture Capital-Backed Newton, MA
Keros Therapeutics Biotechnology Publicly Held Formerly VC-backed Lexington, MA
Myeloma Investment Fund Norwalk, CT
Proximity Therapeutics Biotechnology Privately Held (backing) Venture Capital-Backed Cambridge, MA
SwanBio Therapeutics Drug Discovery Acquired/Merged (Operating Subsidiary) Formerly VC-backed Bala Cynwyd, PA

Julius Knowles Ph.D Lead Partner on Deals (12)

Julius Knowles Ph.D has been the lead partner on 12 deals. Their latest deal was with ROME Therapeutics, a drug discovery company. The deal was made for on 14-Aug-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
ROME Therapeutics 14-Aug-2023 Early Stage VC (Series B) Completed Drug Discovery Boston, MA
Abcuro 11-Aug-2023 Completed Drug Discovery Newton, MA
SwanBio Therapeutics 08-May-2022 Completed Drug Discovery Bala Cynwyd, PA
Paros Bio 01-Aug-2021 Completed Biotechnology Boston, MA
Abcuro 07-Jan-2021 Completed Drug Discovery Newton, MA
Abcuro 07-Jan-2021 Completed Drug Discovery Newton, MA
ROME Therapeutics 27-Apr-2020 Completed Drug Discovery Boston, MA
SwanBio Therapeutics 23-Apr-2020 Completed Drug Discovery Bala Cynwyd, PA
Keros Therapeutics 04-Mar-2020 Later Stage VC (Series C) Completed Biotechnology Lexington, MA
Keros Therapeutics 07-Jan-2019 Early Stage VC (Series B) Completed Biotechnology Lexington, MA

Julius Knowles Ph.D Network (138)

Board Members (84)

Name Company Representing Location From
Ohad Hammer Keros Therapeutics Pontifax Venture Capital Lexington, MA
Alex Martin Abcuro Self Newton, MA
Abcuro Self Newton, MA
Tilos Therapeutics Self Lexington, MA
ROME Therapeutics Self Boston, MA

Portfolio Executives (51)

Name Company Role Deal date Location
Wenyan Miao Ph.D ROME Therapeutics Vice President, Immunology 14-Aug-2023 Boston, MA
Heike Keilhack Ph.D ROME Therapeutics Chief Scientific Officer 14-Aug-2023 Boston, MA
ROME Therapeutics Co-Founder & Board Member 14-Aug-2023 Boston, MA
ROME Therapeutics Chief Financial Officer & Chief Business Officer 14-Aug-2023 Boston, MA
ROME Therapeutics Scientific Co-Founder 14-Aug-2023 Boston, MA

Julius Knowles Ph.D Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Partners Innovation Fund II Mass General Brigham Innovation Venture Capital - Early Stage Closed 2016
Mass General Brigham Fund III Mass General Brigham Ventures Venture - General Closed 2021

Julius Knowles Ph.D FAQs

  • Who is Julius Knowles Ph.D?

    Dr. Julius Knowles serves as a Partner at Mass General Brigham.

  • How much does Julius Knowles Ph.D typically invest?

    Julius Knowles Ph.D's median deal size is .

  • What is Julius Knowles Ph.D’s main position?

    Julius Knowles Ph.D’s primary position is Partner.

  • What are the contact details for Julius Knowles Ph.D?

    Julius Knowles Ph.D’s email address is jj and his phone number is +1 (617) .

  • How many active board seats does Julius Knowles Ph.D hold?

    Julius Knowles Ph.D holds 5 board seats including Abcuro, Keros Therapeutics, Myeloma Investment Fund, Proximity Therapeutics, and SwanBio Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »